Business Context and Reporting Period
This Form 8-K filing by ReWalk Robotics Ltd. (noted as Lifeward Ltd. in metadata) covers events occurring on January 12, 2016. The report addresses corporate governance changes regarding the composition of the Board of Directors and the Audit Committee to ensure compliance with Nasdaq listing rules.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and governance matters rather than financial performance.
Material Changes
- Resignation: Wayne B. Weisman resigned from the Audit Committee effective January 12, 2016, due to independence concerns arising from his affiliation with SCP Vitalife Partners, a greater than 10% shareholder. He remains a member of the Board of Directors.
- Appointment: Jay Kalish was appointed to the Board of Directors and the Audit Committee effective January 12, 2016.
- Compliance: The appointment restores the Audit Committee to a fully independent status as required by Rule 10A-3(b)(1) of the Exchange Act and Nasdaq corporate governance rules.
Outlook, Risks, and Management Commentary
Management views Mr. Kalish's appointment as an interim measure while the Company continues its search for a permanent appointee to the Audit Committee. Mr. Kalish will serve as a Class II director until the 2016 annual meeting of shareholders. There are no disclosed risks, contingencies, or unusual items related to financial operations in this filing.
Key Facts for Investor Verification
- Verify the independence status of the new Audit Committee member, Jay Kalish, under Nasdaq rules.
- Confirm the timeline for the Company's search for a permanent Audit Committee member to replace the interim appointment.
- Review the standard compensation policy for non-employee directors adopted on December 3, 2015, which applies to Mr. Kalish.
- Note that Wayne B. Weisman remains on the Board of Directors despite stepping down from the Audit Committee.